» Articles » PMID: 39684911

Network Pharmacology, Molecular Docking, and In Vitro Insights into the Potential of for Alzheimer's Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Dec 17
PMID 39684911
Authors
Affiliations
Soon will be listed here.
Abstract

Korth. Havil (MS) has a traditional use in relieving pain, managing hypertension, treating cough, and diarrhea, and as a morphine substitute in addiction recovery. Its potential in addressing Alzheimer's disease (AD), a neurodegenerative condition with no effective treatments, is under investigation. This study aims to explore MS mechanisms in treating AD through network pharmacology, molecular docking, and in vitro studies. Using network pharmacology, we identified 19 MS components that may affect 60 AD-related targets. The compound-target network highlighted significant interactions among 60 nodes and 470 edges, with an average node degree of 15.7. The KEGG enrichment analysis revealed Alzheimer's disease (hsa05010) as a relevant pathway. We connected 20 targets to tau and β-amyloid proteins through gene expression data from the AlzData database. Docking studies demonstrated high binding affinities of MS compounds like acetylursolic acid, beta-sitosterol, isomitraphylline, and speciophylline to AD-related proteins, such as AKT1, GSK3B, NFκB1, and BACE1. In vitro studies showed that ethanolic (EE), distilled water (DWE), and pressurized hot water (PHWE) extracts of MS-treated 100 μM HO-induced SH-SY5Y cells significantly reduced oxidative damage. This research underscores the multi-component, multi-target, and multi-pathway effects of MS on AD, providing insights for future research and potential clinical applications.

References
1.
Sadef Y, Javed T, Javed R, Mahmood A, Alwahibi M, Elshikh M . Nutritional status, antioxidant activity and total phenolic content of different fruits and vegetables' peels. PLoS One. 2022; 17(5):e0265566. PMC: 9098067. DOI: 10.1371/journal.pone.0265566. View

2.
Hopkins A . Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008; 4(11):682-90. DOI: 10.1038/nchembio.118. View

3.
Banerjee P, Kemmler E, Dunkel M, Preissner R . ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2024; 52(W1):W513-W520. PMC: 11223834. DOI: 10.1093/nar/gkae303. View

4.
Andronie-Cioara F, Ardelean A, Nistor-Cseppento C, Jurcau A, Jurcau M, Pascalau N . Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer's Disease Progression. Int J Mol Sci. 2023; 24(3). PMC: 9915182. DOI: 10.3390/ijms24031869. View

5.
Ignat I, Volf I, Popa V . A critical review of methods for characterisation of polyphenolic compounds in fruits and vegetables. Food Chem. 2014; 126(4):1821-35. DOI: 10.1016/j.foodchem.2010.12.026. View